APA Citatie

Papamichael, K., Chachu, K. A., Vajravelu, R., Vaughn, B. P., Ni, J., Osterman, M. T., & Cheifetz, A. S. (2017). Improved Long-Term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab. Clin Gastroenterol Hepatol.

Chicago Style citaat

Papamichael, Konstantinos, Karen A. Chachu, Ravy Vajravelu, Byron P. Vaughn, Josephine Ni, Mark T. Osterman, en Adam S. Cheifetz. "Improved Long-Term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab." Clin Gastroenterol Hepatol 2017.

MLA citatie

Papamichael, Konstantinos, et al. "Improved Long-Term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab." Clin Gastroenterol Hepatol 2017.